How much funding has Stentit raised?

Stentit has raised $15.5M in total funding, most recently a Grant round.

Who are Stentit's investors?

Stentit's investors include European Innovation Council Fund.

Where is Stentit headquartered?

Stentit is headquartered in Eindhoven.

What industry is Stentit in?

Stentit operates in Biotech, Healthcare.

Stentit

The next generation in stent technology

Eindhoven · $15.5M raised

Biotech

Healthcare

Headquarters: Eindhoven
Employees: 1–10
Business Model: B2B
Website: stentit.com

Total Funding: $15.5M
Last Round: $2.5M GrantJun 2023
Rounds: 3

About

STENTiT is a Dutch MedTech company transforming vascular reconstruction through its Resorbable Fibrillated Scaffold (RFS), a temporary vascular support structure that triggers a natural healing response to regrow an artery from the inside out. It initially targets below-the-knee chronic limb-threatening ischemia (CLTI), a condition affecting 3.5 million patients in the EU and US, and is led by CEO and founder Bart Sanders.

Summary

Stentit is a Biotech company based in Eindhoven. It has raised $15.5M in total across 3 rounds, most recently a $2.5M Grant round in Jun 2023. Investors include European Innovation Council Fund.